Anlotinib With Trastuzumab Deruxtecan for Previously Treated HER2-Low Advanced Breast Cancer
Clinical trial NCT06331169 · RECRUITING
Trial details
- NCT number
- NCT06331169
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-31
- Primary completion
- 2026-12-31
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.